본문으로 건너뛰기
← 뒤로

Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review.

메타분석 1/5 보강
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 📖 저널 OA 21.2% 2021: 0/2 OA 2022: 1/3 OA 2023: 1/1 OA 2024: 2/3 OA 2025: 2/6 OA 2026: 1/6 OA 2021~2026 2026 Vol.39(2)
Retraction 확인
출처

Abdel Fattah AR, Mahdy K, Abdelhamid A, Nanthakumaran S, Ramsay G

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.7%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

📝 환자 설명용 한 줄

Paraconduit hiatal hernia (PCH) is a serious complication following esophagectomy with significant morbidity and mortality.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P = 0.04
  • p-value P < 0.01
  • 95% CI 1.60-5.55
  • OR 3.03
  • HR 1.56

이 논문을 인용하기

↓ .bib ↓ .ris
APA Abdel Fattah AR, Mahdy K, et al. (2026). Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review.. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 39(2). https://doi.org/10.1093/dote/doag017
MLA Abdel Fattah AR, et al.. "Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review.." Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, vol. 39, no. 2, 2026.
PMID 41766592 ↗

Abstract

Paraconduit hiatal hernia (PCH) is a serious complication following esophagectomy with significant morbidity and mortality. We aimed to conduct a comprehensive review to describe the prognostic factors for PCH in adult patients following esophagectomy for esophageal or gastric cancer to better understand which patients at risk. A systematic search was carried out in Ovid MEDLINE, Embase and Web-of-Science, from inception to August-2024. All studies of adult patients assessing risk factors for radiologically-confirmed PCH following esophagectomy for upper gastrointestinal cancers were included. The data showed that a minimally-invasive esophagectomy was associated with a significant increase in risk of developing PCH (odds ratio [OR]: 4.29, 95% confidence interval [CI]: 1.09-16.87; P = 0.04), particularly following laparoscopic-abdominal approach (hazard ratio [HR]: 2.98, 95% CI: 1.60-5.55; P < 0.01), and a 203% increase following extensive lymphadenectomy (OR: 3.03, 95% CI: 1.14-8.05; P = 0.03). A prophylactic-cruroplasty was not found to be associated with this complication (P = 0.18). Neoadjuvant-chemotherapy and neoadjuvant-chemoradiotherapy (nCRT) were both found to be associated with an increased risk of PCH (HR: 1.56, 95% CI: 0.58-4.17, P < 0.01; HR: 4.27 95% CI: 1.70-10.76; P < 0.01). Tumors located at gastro-esophageal-junction (GOJ) were associated with the greatest risk (HR: 3.51, 95% CI: 1.91-6.45; P < 0.01). In terms of clinical risk factors, patients with body-mass index (BMI) <25 (OR: 2.00, 95% CI: 1.10-3.70; P = 0.03), a pre-operative hiatus hernia (HH) (HR: 1.72, 95% CI: 1.01-2.94; P < 0.05) and those who had previous hiatal-surgery (HR:3.68, 95% CI: 1.61-8.45; P < 0.01) were associated with increased risk of developing PCH. The current literature suggests an associative trend between patients with BMI less than 25; nCRT; laparoscopic resection; GOJ tumor location; previous HH or hiatal surgery, and developing a PCH post-operatively.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반